Literature DB >> 19437063

De novo and rescue DBS leads for refractory Tourette syndrome patients with severe comorbid OCD: a multiple case report.

Domenico Servello1, Marco Sassi, Arianna Brambilla, Mauro Porta, Ihtsham Haq, Kelly D Foote, Michael S Okun.   

Abstract

Invasive treatment for Gilles de la Tourette syndrome has shown interesting results in a number of published reports; it seems to be evolving into a promising therapeutic procedure for those patients demonstrating disabling clinical pictures who are refractory to conservative treatments. There are important issues concerning the stimulated brain target, with different nuclei currently under investigation. Our group asked in this pilot study whether Tourette syndrome could be treated by tailoring specific brain targets for specific symptoms. Deep brain stimulation for Tourette syndrome may thus in the future be tailored and patient specific, utilizing specific target regions for individual clinical manifestations. In our early experience we did not adequately address non-motor clinical symptoms as we only used a thalamic target. More recently in an obsessive compulsive disease cohort we have had success in using the anterior limb of the internal capsule and nucleus accumbens region as targets for stimulation. We therefore explored the option of a "rescue" procedure for our Tourette patients with persistent obsessive-compulsive disorder following ventralis oralis/centromedianus-parafascicularis (Vo/CM-Pf) deep brain stimulation. Following two cases where rescue anterior limb of internal capsule/nucleus accumbens leads were employed, we performed two additional procedures (anterior limb of the internal capsule plus ventralis oralis/centromedianus-parafascicularis and anterior limb of the internal capsule alone) with some mild improvement of comorbid obsessive-compulsive disorder, although the number of observations in this case series was low. Overall, the effects observed with using the anterior limb of the internal capsule either alone or as a rescue were less than expected. In this report we detail our experience with this approach.

Entities:  

Mesh:

Year:  2009        PMID: 19437063     DOI: 10.1007/s00415-009-5159-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  28 in total

1.  Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life?

Authors:  A G E M de Boer; J J B van Lanschot; P F M Stalmeier; J W van Sandick; J B F Hulscher; J C J M de Haes; M A G Sprangers
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

2.  Deep brain stimulation of the anterior internal capsule for the treatment of Tourette syndrome: technical case report.

Authors:  Alice W Flaherty; Ziv M Williams; Ramin Amirnovin; Ekkehard Kasper; Scott L Rauch; G Rees Cosgrove; Emad N Eskandar
Journal:  Neurosurgery       Date:  2005-10       Impact factor: 4.654

Review 3.  Deep brain stimulation for neurologic and neuropsychiatric disorders.

Authors:  Thomas Wichmann; Mahlon R Delong
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

4.  Internal pallidal and thalamic stimulation in patients with Tourette syndrome.

Authors:  Marie-Laure Welter; Luc Mallet; Jean-Luc Houeto; Carine Karachi; Virginie Czernecki; Philippe Cornu; Soledad Navarro; Bernard Pidoux; Didier Dormont; Eric Bardinet; Jérôme Yelnik; Philippe Damier; Yves Agid
Journal:  Arch Neurol       Date:  2008-07

5.  Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience.

Authors:  B D Greenberg; L A Gabriels; D A Malone; A R Rezai; G M Friehs; M S Okun; N A Shapira; K D Foote; P R Cosyns; C S Kubu; P F Malloy; S P Salloway; J E Giftakis; M T Rise; A G Machado; K B Baker; P H Stypulkowski; W K Goodman; S A Rasmussen; B J Nuttin
Journal:  Mol Psychiatry       Date:  2008-05-20       Impact factor: 15.992

Review 6.  Tourette's syndrome and role of tetrabenazine: review and personal experience.

Authors:  Mauro Porta; Marco Sassi; Mario Cavallazzi; Maurizio Fornari; Arianna Brambilla; Domenico Servello
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

7.  Deep brain stimulation in Tourette's syndrome: two targets?

Authors:  Linda Ackermans; Yasin Temel; Danielle Cath; Chris van der Linden; Richard Bruggeman; Mariska Kleijer; Pieter Nederveen; Koen Schruers; Henry Colle; Marina A J Tijssen; Veerle Visser-Vandewalle
Journal:  Mov Disord       Date:  2006-05       Impact factor: 10.338

8.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

Authors:  W K Goodman; L H Price; S A Rasmussen; C Mazure; R L Fleischmann; C L Hill; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1989-11

9.  Deep brain stimulation of the nucleus accumbens and the internal capsule in therapeutically refractory Tourette-syndrome.

Authors:  Jens Kuhn; Doris Lenartz; Jürgen K Mai; Wolfgang Huff; Sun-Hee Lee; Athanasios Koulousakis; Joachim Klosterkoetter; Volker Sturm
Journal:  J Neurol       Date:  2007-04-06       Impact factor: 4.849

10.  Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation.

Authors:  D Servello; M Porta; M Sassi; A Brambilla; M M Robertson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-09-10       Impact factor: 10.154

View more
  25 in total

1.  A method for pre-operative single-subject thalamic segmentation based on probabilistic tractography for essential tremor deep brain stimulation.

Authors:  Erik H Middlebrooks; Vanessa M Holanda; Ibrahim S Tuna; Hrishikesh D Deshpande; Markus Bredel; Leonardo Almeida; Harrison C Walker; Barton L Guthrie; Kelly D Foote; Michael S Okun
Journal:  Neuroradiology       Date:  2018-01-06       Impact factor: 2.804

Review 2.  Deep brain stimulation (DBS) at the interface of neurology and psychiatry.

Authors:  Nolan R Williams; Michael S Okun
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

3.  A Case of Deep Brain Stimulation for Tourette's Complicated by Twiddler's Syndrome.

Authors:  Michael H Pourfar; Cathy L Budman; Alon Y Mogilner
Journal:  Mov Disord Clin Pract       Date:  2015-02-16

Review 4.  Deep brain stimulation.

Authors:  X L Chen; Y Y Xiong; G L Xu; X F Liu
Journal:  Interv Neurol       Date:  2013-09

Review 5.  Updates in medical and surgical therapies for Tourette syndrome.

Authors:  Irene A Malaty; Umer Akbar
Journal:  Curr Neurol Neurosci Rep       Date:  2014-07       Impact factor: 5.081

6.  European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation.

Authors:  Kirsten R Müller-Vahl; Danielle C Cath; Andrea E Cavanna; Sandra Dehning; Mauro Porta; Mary M Robertson; Veerle Visser-Vandewalle
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

7.  STN vs. GPi Deep Brain Stimulation: Translating the Rematch into Clinical Practice.

Authors:  Nolan R Williams; Kelly D Foote; Michael S Okun
Journal:  Mov Disord Clin Pract       Date:  2014-04-01

8.  Deep brain stimulation of the globus pallidus internus and Gilles de la Tourette syndrome: Toward multiple networks modulation.

Authors:  Christian Saleh; Victoria Gonzalez; Laura Cif; Philippe Coubes
Journal:  Surg Neurol Int       Date:  2012-04-26

9.  Increased thalamic gamma band activity correlates with symptom relief following deep brain stimulation in humans with Tourette's syndrome.

Authors:  Nicholas Maling; Rowshanak Hashemiyoon; Kelly D Foote; Michael S Okun; Justin C Sanchez
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

10.  Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Meta-Analysis of Treatment Outcome and Predictors of Response.

Authors:  Pino Alonso; Daniel Cuadras; Loes Gabriëls; Damiaan Denys; Wayne Goodman; Ben D Greenberg; Fiacro Jimenez-Ponce; Jens Kuhn; Doris Lenartz; Luc Mallet; Bart Nuttin; Eva Real; Cinto Segalas; Rick Schuurman; Sophie Tezenas du Montcel; Jose M Menchon
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.